Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04099641
Title An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oncologie Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR


No variant requirements are available.